In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
- PMID: 29633177
- PMCID: PMC5986684
- DOI: 10.1007/s40121-018-0200-7
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
Abstract
Introduction: Recent virus epidemics and rising antibiotic resistance highlight the importance of hygiene measures to prevent and control outbreaks. We investigated the in vitro bactericidal and virucidal efficacy of povidone-iodine (PVP-I) 7% gargle/mouthwash at defined dilution against oral and respiratory tract pathogens.
Methods: PVP-I was tested against Klebsiella pneumoniae and Streptococcus pneumoniae according to bactericidal quantitative suspension test EN13727 and against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses (SARS-CoV and MERS-CoV), rotavirus strain Wa and influenza virus A subtype H1N1 according to virucidal quantitative suspension test EN14476. PVP-I 7% gargle/mouthwash was diluted 1:30 with water to a concentration of 0.23% (the recommended concentration for "real-life" use in Japan) and tested at room temperature under clean conditions [0.3 g/l bovine serum albumin (BSA), viruses only] and dirty conditions (3.0 g/l BSA + 3.0 ml/l erythrocytes) as an interfering substance for defined contact times (minimum 15 s). Rotavirus was tested without protein load. A ≥ 5 log10 (99.999%) decrease of bacteria and ≥ 4 log10 (99.99%) reduction in viral titre represented effective bactericidal and virucidal activity, respectively, per European standards.
Results: PVP-I gargle/mouthwash diluted 1:30 (equivalent to a concentration of 0.23% PVP-I) showed effective bactericidal activity against Klebsiella pneumoniae and Streptococcus pneumoniae and rapidly inactivated SARS-CoV, MERS-CoV, influenza virus A (H1N1) and rotavirus after 15 s of exposure.
Conclusion: PVP-I 7% gargle/mouthwash showed rapid bactericidal activity and virucidal efficacy in vitro at a concentration of 0.23% PVP-I and may provide a protective oropharyngeal hygiene measure for individuals at high risk of exposure to oral and respiratory pathogens.
Funding: Mundipharma Research GmbH & Co. KG (MRG).
Keywords: Anti-infective agents; Local; Microbial sensitivity tests; Mouthwashes; Povidone-iodine; Respiratory tract infections.
Similar articles
-
A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.Sr Care Pharm. 2021 May 1;36(5):238-241. doi: 10.4140/TCP.n.2021.238. Sr Care Pharm. 2021. PMID: 33879284 Review.
-
Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update.Jpn Dent Sci Rev. 2021 Nov;57:39-45. doi: 10.1016/j.jdsr.2021.03.001. Epub 2021 Mar 15. Jpn Dent Sci Rev. 2021. PMID: 33747261 Free PMC article. Review.
-
In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice.Br Dent J. 2020 Dec 10:1-4. doi: 10.1038/s41415-020-2402-0. Online ahead of print. Br Dent J. 2020. PMID: 33303923 Free PMC article.
-
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.Infect Dis Ther. 2020 Sep;9(3):669-675. doi: 10.1007/s40121-020-00316-3. Epub 2020 Jul 8. Infect Dis Ther. 2020. PMID: 32643111 Free PMC article.
-
Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA).Infect Dis Ther. 2015 Dec;4(4):491-501. doi: 10.1007/s40121-015-0091-9. Epub 2015 Sep 28. Infect Dis Ther. 2015. PMID: 26416214 Free PMC article.
Cited by
-
Lessons should be learned: Why did we not learn from the Spanish flu?SAGE Open Med. 2024 May 29;12:20503121241256820. doi: 10.1177/20503121241256820. eCollection 2024. SAGE Open Med. 2024. PMID: 38826825 Free PMC article. Review.
-
Guidelines for dental implants in the times of COVID-19.Natl J Maxillofac Surg. 2024 Jan-Apr;15(1):23-28. doi: 10.4103/njms.njms_450_21. Epub 2024 Mar 19. Natl J Maxillofac Surg. 2024. PMID: 38690255 Free PMC article. Review.
-
Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.BMC Oral Health. 2024 Apr 25;24(1):491. doi: 10.1186/s12903-024-04246-1. BMC Oral Health. 2024. PMID: 38664718 Free PMC article. Clinical Trial.
-
Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management).BMC Infect Dis. 2024 Mar 1;24(1):271. doi: 10.1186/s12879-024-09137-y. BMC Infect Dis. 2024. PMID: 38429662 Free PMC article. Clinical Trial.
-
Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.BMC Oral Health. 2023 Jul 3;23(1):443. doi: 10.1186/s12903-023-03126-4. BMC Oral Health. 2023. PMID: 37400836 Free PMC article.
References
-
- World Health Organization. Antibiotic resistance fact sheet. 2016. http://www.who.int/mediacentre/factsheets/antibiotic-resistance/en/. Accessed Mar 2018.
-
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2013. https://www.cdc.gov/drugresistance/threat-report-2013/. Accessed Mar 2018.
-
- World Health Organization. Resistant pneumococcal infections; the burden of disease and challenges in monitoring and controlling antimicrobial resistance. 2001. http://www.who.int/drugresistance/technicalguidance/en/resistantinfectio.... Accessed Mar 2018.
-
- World Health Organization. Influenza (seasonal) fact sheet. 2016. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed Mar 2018.
-
- World Health Organization. Frequently asked questions on Middle East respiratory syndrome coronavirus (MERS-CoV). 2015. http://www.who.int/csr/disease/coronavirus_infections/faq/en/. Accessed Mar 2018.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous